Main
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
Register:
|
ClinicalTrials.gov |
Last refreshed on:
|
12 December 2020 |
Main ID: |
NCT03119337 |
Date of registration:
|
31/03/2017 |
Prospective Registration:
|
Yes |
Primary sponsor: |
|
Public title:
|
Text-based Follow-up in Zimbabwe's Voluntary Medical Male Circumcision Program
2WT |
Scientific title:
|
Reducing Provider Workload While Preserving Patient Safety: A 2-Way Texting Intervention in Zimbabwe's Voluntary Medical Male Circumcision Program |
Date of first enrolment:
|
June 18, 2018 |
Target sample size:
|
780 |
Recruitment status: |
Completed |
URL:
|
https://clinicaltrials.gov/show/NCT03119337 |
Study type:
|
Interventional |
Study design:
|
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Health Services Research. Masking: None (Open Label).
|
Phase:
|
N/A
|
|
Countries of recruitment
|
Zimbabwe
| | | | | | | |
Contacts
|
Name:
|
Caryl Feldacker, PhD, MPH |
Address:
|
|
Telephone:
|
|
Email:
|
|
Affiliation:
|
University of Washington |
| | |
Key inclusion & exclusion criteria
|
Inclusion: For health care workers (Aim 3):
1. are employees posted at the site;
2. are at least 18 years of age or over;
3. provide health care services to patients as part of the VMMC programs; and
4. are able to provide written informed consent.
For VMMC clients (Aims 1): Eligibility criteria for VMMC clients are:
1. 18 years or older;
2. possession of own phone at enrollment;
3. provides contact details (phone, physical location);
4. receives surgical VMMC;
5. willing to follow MoHCC VMMC protocols;
6. willing to come in Day 14;
7. Able and willing to respond to a questionnaire administered by phone 42 days after
circumcision.
Exclusion for Healthcare workers:
1. not willing to participate
2. not willing to be recorded
Exclusion for VMMC clients:
1. men without cell phones;
2. those who chose PrePex as PrePex requires a device-removal visit 7 days after
placement and has distinctly different follow-up protocols;
3. men who have an inter-operative AE during routine VMMC will be withdrawn from the
study as these men will have known, additional follow-up risks and mandatory in-person
visits.
Age minimum:
18 Years
Age maximum:
65 Years
Gender:
All
|
Health Condition(s) or Problem(s) studied
|
Voluntary Medical Male Circumcision
|
Intervention(s)
|
Other: Text-based follow-up
|
Primary Outcome(s)
|
Mean number of in-person visits
[Time Frame: Before 42 day visit for each participant with analysis completed in year 1.]
|
2WT acceptability
[Time Frame: The acceptability activities will be completed by April 2018 at the completion of all study participant follow-up with analysis to commence after that point. Analysis will conclude in year 1.]
|
2WT feasibility
[Time Frame: The feasibility activities be completed by April 2018 at the completion of all study participant follow-up with analysis to commence after that point. Analysis will conclude in year 1.]
|
2wT costs
[Time Frame: The costing data collection will be completed by April 2018 at the completion of all study participant follow-up. Analysis will conclude in year 1]
|
Cumulative adverse event (AE) rate (moderate or severe)
[Time Frame: = Day 14 for each participant with analysis completed in year 1.]
|
Secondary Outcome(s)
|
AE rates on Day 14
[Time Frame: Day 14 data collection for each participant with analysis to be completed in year 1.]
|
time between 2wT AE text reporting and follow-up
[Time Frame: Day 14 data collection for each participant with analysis to be completed in year 1.]
|
severity of AEs.
[Time Frame: Day 14 data collection for each participant with analysis to be completed in year 1.]
|
Secondary ID(s)
|
STUDY00001839
|
Source(s) of Monetary Support
|
Please refer to primary and secondary sponsors
|
Results
|
Results available:
|
|
Date Posted:
|
|
Date Completed:
|
|
URL:
|
|
|
|